MSN Laboratories Private Limited — Pomalidomide Exporter Profile
Indian Pharmaceutical Exporter · #1 for Pomalidomide · $950.0K export value · DGFT Verified
MSN Laboratories Private Limited is the #1 Indian exporter of Pomalidomide with $950.0K in export value and 19 verified shipments. MSN Laboratories Private Limited holds a 21.5% market share in Pomalidomide exports across 3 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Pomalidomide Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Pomalidomide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $450.0K | 9 | 53.1% |
| PERU | $302.6K | 8 | 35.7% |
| UNITED ARAB EMIRATES | $95.4K | 2 | 11.2% |
MSN Laboratories Private Limited exports Pomalidomide to 3 countries. The largest destination is COLOMBIA accounting for 53.1% of MSN Laboratories Private Limited's Pomalidomide shipments, followed by PERU (35.7%) and UNITED ARAB EMIRATES (11.2%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pomalidomide from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MSN LABS PERU SAC | PERU | $240.1K | 6 |
| TO THE ORDER MSN LABS AMERICAS SAS | COLOMBIA | $150.0K | 3 |
| MSN LABS AMERICAS SAS | COLOMBIA | $150.0K | 3 |
| MSN LABS AMERICAS SASNIT | COLOMBIA | $100.0K | 2 |
| WORLD HEALTH ORGANIZATION WAREHOUSE | UNITED ARAB EMIRATES | $95.4K | 2 |
| TO THE ORDER OF | PERU | $50.0K | 1 |
| MSN LABS AMERICAS SAS NIT | COLOMBIA | $50.0K | 1 |
| MSN LABS PERU SACCAL AMADOR MERINO REYNA NRO | PERU | $12.5K | 1 |
MSN Laboratories Private Limited supplies Pomalidomide to 8 buyers globally. The largest buyer is MSN LABS PERU SAC (PERU), followed by TO THE ORDER MSN LABS AMERICAS SAS (COLOMBIA) and MSN LABS AMERICAS SAS (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pomalidomide Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $1.2M worth of Pomalidomide through 662 shipments from 108 suppliers to 52 countries, serving 190 buyers globally. MSN Laboratories Private Limited contributes $950.0K to this total, accounting for 21.5% of India's Pomalidomide exports. MSN Laboratories Private Limited ships Pomalidomide to 3 countries through 8 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Pomalidomide Exports?
MSN Laboratories Private Limited's average Pomalidomide shipment value is $50.0K per consignment, based on 19 shipments totaling $950.0K. The largest destination is COLOMBIA (53.1% of MSN Laboratories Private Limited's Pomalidomide exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Pomalidomide Exporters?
MSN Laboratories Private Limited ranks #1 among 108 Indian Pomalidomide exporters with a 21.5% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($950.0K), NATCO PHARMA LIMITED ($64.6K), HETERO LABS LIMITED ($32.3K). MSN Laboratories Private Limited processed 19 shipments to 3 destination countries.
What Pomalidomide Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IPOPRIN 4 (POMALIDOMIDE 4MG) 1X21 | $100.0K | 2 |
| POMALIDOMIDE 4MG 1X21 S AURUGULF AE | $50.0K | 1 |
| MSN PHARMACEUTICAL PRODUCT NAME POMALID4MG POMALIDOMIDE 4MG 70 PACKS OF 21 S AS PER INV | $50.0K | 1 |
| MSN PHARMACEUTICAL PRODUCT NAME: IPOPRIN3POMALIDOMIDE 3MG 1x21 | $50.0K | 1 |
| IPOPRIN 2 POMALIDOMIDE 2MG 1X21 | $50.0K | 1 |
| IPOPRIN 4 POMALIDOMIDE 4MG 1X21 | $50.0K | 1 |
| IPOPRIN 3 POMALIDOMIDE 3MG 1X21 | $50.0K | 1 |
| IPOPRIN 2POMALIDOMIDE 2MG1X21 | $50.0K | 1 |
| IPOPRIN 3POMALIDOMIDE 3MG1X21 | $50.0K | 1 |
| POMALID 4 MD POMALIDOMIDE 4MG 1x21's | $50.0K | 1 |
MSN Laboratories Private Limited exports 18 distinct Pomalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IPOPRIN 4 (POMALIDOMIDE 4MG) 1X21 with 2 shipments worth $100.0K.
How Does MSN Laboratories Private Limited Compare to Nearest Pomalidomide Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED ★ | $950.0K | 19 | 3 | $50.0K |
| 2 | NATCO PHARMA LIMITED | $64.6K | 5 | 2 | $12.9K |
| 3 | HETERO LABS LIMITED | $32.3K | 7 | 2 | $4.6K |
MSN Laboratories Private Limited ranks #1 among 108 Indian Pomalidomide exporters. Average shipment value of $50.0K compared to the market average of $11.2K. The closest competitors by value are NATCO PHARMA LIMITED and HETERO LABS LIMITED.
Which Indian Ports Ship Pomalidomide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 223 | 33.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 188 | 28.4% |
| Bombay Air | 49 | 7.4% |
| Bombay Air Cargo | 31 | 4.7% |
| DELHI AIR | 30 | 4.5% |
| HYDERABAD AIR | 21 | 3.2% |
| DELHI AIR CARGO ACC (INDEL4) | 13 | 2.0% |
| HYDERABAD ACC (INHYD4) | 13 | 2.0% |
What Other Advanced Oncology Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Pomalidomide Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Pomalidomide, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pomalidomide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pomalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching MSN Laboratories Private Limited exporting Pomalidomide, covering 18 formulations to 3 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 52+ countries, 190+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pomalidomide Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Pomalidomide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Pomalidomide Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pomalidomide. For current shipment-level data, contact TransData Nexus.